7 latest FDA approvals

Here are the seven latest drugs or medical devices approved by the Food and Drug Administration since June 9.

  1. The Quantiferon-TB Gold Plus blood test is designed to detect latent tuberculosis in patients.

  1. Teva Pharmaceuticals gained approval for the first generic version of Gilead Science's best-selling HIV drug Truvada.

  1. Symjepi is a single-dose prefilled syringe of epinephrine intended to treat emergency allergic reactions, including anaphylaxis.

  1. Mydayis is intended to treat ADHD symptoms in patients thirteen years or older.

  1. Cotempla is an extended-release orally disintegrating tablet intended to treat ADHD in patients ages 6 to 17 years.

  1. Baxdela is intended to treat skin and skin structure infections caused by various gram-positive and gram-negative bacteria, including methicillin-resistant Staphylococcus aureus.

  1. Haegarda is the first self-administered C1 esterase inhibitor subcutaneous injection to prevent swelling attacks in patients with hereditary angiodema.

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars